article thumbnail

Contrave alternatives: What can I take instead?

The Checkup by Singlecare

mg capsule or tablet once daily Adipex-P coupons Wegovy (semaglutide) Treatment of obesity and chronic weight management, in addition to diet and exercise; reduce cardiovascular events Begin with 0.25mg injection once weekly; maximum dose 2.4 Due to the phentermine component, Qsymia is classified as a Schedule IV controlled substance.

article thumbnail

Bring Out Your Meds! Bring Out Your Meds!

The FDA Law Blog

DEA holds the popular take back event each spring and autumn. DEA and its law enforcement partners will once again host local drop-off locations nationwide for safe disposal of unneeded medication on Saturday, October 26, 2024, from 10:00 a.m. to 2:00 p.m. local time. DEA has collected over 18.5 million pounds of medication since 2010.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Compass plans $100m IPO to fund magic mushroom depression drug

pharmaphorum

There have been issues with COMP360 so far though – one patient experienced adjustment disorder which can occur after a stressful life event, which was thought to be related to the treatment. Another was hospitalised with suicidal ideation. The post Compass plans $100m IPO to fund magic mushroom depression drug appeared first on.

article thumbnail

Pharmacies Selling PSE: Remember to Train Employees and Self-Certify

The FDA Law Blog

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ).

article thumbnail

“Thaw Out” with Pharma Thought Leaders at the 2024 Puerto Rico Pharmaceutical Summit: HPM Directors to Discuss Drug Approvals and Puerto Rico “Exportation” Best Practices

The FDA Law Blog

This day-long (FREE) seminar is a must-attend event for anyone in the pharmaceutical sector interested in understanding the “ins and outs” of doing business in the Territory, as well as an opportunity to interact with those who already have a keen understanding of doing business in Puerto Rico. HPM is a co-sponsor of the event.

article thumbnail

HP&M’s Larry Houck A Panelist at FDLI’s Cannabis Regulation Conference

The FDA Law Blog

Last August the Food and Drug Administration (“FDA”)/Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule cannabis from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. April 4th and 5th, is an in-person and virtual event.

article thumbnail

Vyvanse generic availability, cost, and dosage

The Checkup by Singlecare

It is a Drug Enforcement Administration (DEA) controlled substance in the Schedule II category. Non-amphetamine-based ADHD treatments, such as Strattera , are not controlled substances. Food and Drug Administration (FDA) in 2007 for treatment and symptom control in ADHD. Vyvanse was initially approved by the U.S.

Dosage 92